Fed. Circ. Urged Not To Rehear Generics Jurisdiction Ruling
AstraZeneca AB and Acorda Therapeutics Inc. have urged the full Federal Circuit not to review a panel's opinion that Mylan must face patent infringement suits in the Delaware federal court, saying...To view the full article, register now.
Already a subscriber? Click here to view full article